Carcinoembryonic antigen-related cell adhesion molecule 1a-4L suppression of rat hepatocellular carcinomas

Nikia A Laurie1, Meghan M Comegys, Marie P Carreiro

  • 1Division of Hematology and Oncology, Department of Medicine, Rhode Island Hospital/Brown University Medical School, Providence, Rhode Island 02903, USA.

Cancer Research
|December 3, 2005
PubMed

Insights

Restoring Carcinoembryonic antigen (CEA)-related cell adhesion molecule 1 (CEACAM1) expression suppressed liver cancer growth in a rat model. This finding offers new insights into CEACAM1

Area of Science:

  • Oncology
  • Molecular Biology
  • Cell Adhesion Molecules

Background:

  • Carcinoembryonic antigen (CEA)-related cell adhesion molecule 1 (CEACAM1) is downregulated in various carcinomas.
  • CEACAM1 has two major splice variants: CEACAM1(a)-4L and CEACAM1(b)-4S.
  • Previous studies showed CEACAM1(a)-4L suppresses tumorigenicity in prostate cancer models.

Purpose of the Study:

  • To investigate the effect of CEACAM1(a)-4L on the tumorigenicity of rat hepatocellular carcinoma (1682A).
  • To determine if CEACAM1(a)-4L exhibits tumor suppressive properties in liver cancer.
  • To establish a quantifiable model for studying CEACAM1's role in liver tumorigenesis.

Main Methods:

  • Restoration of CEACAM1(a)-4L expression in 1682A rat hepatocellular carcinoma cells.
  • Intraperitoneal injection of modified 1682A cells into syngeneic rats.
  • Evaluation of tumor nodule formation on the omentum at 3 weeks post-injection.
  • Analysis of cellular aggregates formed in vitro and cell cycle progression.

Main Results:

  • Restoration of CEACAM1(a)-4L completely suppressed the formation of 1682A tumor nodules.
  • CEACAM1(b)-4S or empty vector-infected cells formed multiple tumor nodules.
  • In vitro aggregates of CEACAM1(a)-4L-expressing cells were smaller with enlarged intercellular spaces.
  • CEACAM1(a)-4L expression increased G1 phase length without elevating apoptosis.

Conclusions:

  • CEACAM1(a)-4L demonstrates significant tumor suppressive effects in a rat model of hepatocellular carcinoma.
  • This study provides the first evidence of CEACAM1(a)-4L-induced tumor suppression in liver cancer using a syngeneic transplantation model.
  • CEACAM1(a)-4L may represent a potential therapeutic target for liver cancer treatment.

Related Concept Videos